The AKT and STAT3 signaling pathways can manipulate EMT regulatory factors to activate the genes related to GBM stemness directly or indirectly, such as CD133, CD44, Oct4, SOX2, Nanog, ALDH1A1, Olig2, and Nestin [47]. The gene discussed is AKT1; the disease is glioblastoma.